Studies on cancer chemoprevention by traditional folk medicines XXV. Inhibitory effect of isoliquiritigenin on azoxymethane-induced murine colon aberrant crypt focus formation and carcinogenesis

Biological and Pharmaceutical Bulletin

Volumn 25, Issue 2, 2002, Pages 247-250

  Baba, Masaki ^a   Asano, Ryoya ^a   Takigami, Ikumi ^a   Takahashi, Tetsuyuki ^a   Ohmura, Masayoshi ^a   Okada, Yoshihito ^a   Sugimoto, Hajime ^b   Arika, Tadashi ^b   Nishino, Hoyoku ^c   Okuyama, Toru ^a  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b KAKEN PHARMACEUTICAL CO LTD   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aberrant crypt foci; Cancerprevention; Colon cancer; Isoliquiritigenin

Indexed keywords

ANTINEOPLASTIC AGENT; AZOXYMETHANE; DRINKING WATER; ISOLIQUIRITIGENIN; CHALCONE; CHALCONE DERIVATIVE; DRUG DERIVATIVE;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLON MALFORMATION; CONTROLLED STUDY; DIET; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; TRADITIONAL MEDICINE; ANIMAL; CHEMICALLY INDUCED DISORDER; COLON TUMOR; PRECANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AZOXYMETHANE; CHALCONE; CHALCONES; COLONIC NEOPLASMS; MALE; MICE; PRECANCEROUS CONDITIONS;

EID: 9944237767     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.25.247     Document Type: Article

References (27)

1. This report is Part XXV of the series "Studies on Cancer Chemoprevention by Traditional Folk Medicines." Part XXIV: Baba M., Jin Y., Mizuno A., Suzuki H., Okada Y., Takasuka N., Tokuda H., Nishino H., Okuyama T., Biol. Pharm. Bull., 25, 244-246 (2002).
2. Kumagai A., Pharma Medica, 2, 120 (1984).
3. Baba M., Asano R., Okada Y., Singab A. N., Fushiya S., Shibano M., Kusano G., Okuyama T., Heterocycles. 52, 387-391 (1999).
4. Shibata S., Stem Cells, 12, 44-52 (1994).
5. Yamamoto S., Aizu E., Jiang H., Nakadate T., Kiyoto I., Wang J. C., Kato R., Carcinogenesis, 12, 317-323 (1991).
6. Aida K., Tawata M., Shindo H., Onaya T., Sasaki H., Yamaguchi T., Chin M., Mitsuhashi H., Planta Med., 56, 254-258 (1990).
7. Tawata M., Aida K., Noguchi T., Ozaki Y., Kume S., Sasaki H., Chin M., Onaya T., Eur. J. Pharmacol., 212, 87-92 (1993).
8. Haraguchi H., Ishikawa H., Mizutani K., Tamura Y., Kinoshita T., Bioorg. Med. Chem., 6, 339-347 (1998).
9. Druckrey E., "Topics in Chemical Carcinogenesis," University Park Press, 1972, pp. 73-101.
10. a) Rao C. V., Desai D., Simi B., Kulkarni N., Amin S., Reddy B. S., Cancer Res., 53, 4182-4188 (1993);
11. b) Kawamori T., Tanaka T., Hirose Y., Ohnishi M., Mori H., Carcinogenesis, 17, 369-372 (1996).
12. Bird R. P., Cancer Lett., 93, 55-71 (1995).
13. Roncucci L., Stamp D., Medline A., Cullen J. B., Bruce W. R., Hum. Pathol., 22, 287-294 (1991).
14. Otori K., Konishi M., Sugiyama K., Hasebe T., Shimoda T., Kikuchi-Yanoshita R., Mukai K., Fukushima S., Miyaki M., Esumi H., Cancer, 83, 896-900 (1998).
15. McLellan E. A., Bird R. P., Cancer Res., 48, 6187-6192 (1988).
16. Kawamori T., Tanaka T., Hirose Y., Satoh K., Hara A., Torihara M., Tamai Y., Yamahara J., Mori H., Cancer Lett., 92, 159-165 (1995).
17. Komaki C., Okuno M., Onogi N., Moriwaki H., Kawamori T., Tanaka T., Mori H., Muto Y., Carcinogenesis, 17, 1897-1901 (1996).
18. Hulle C. V., Braeckman P., Vandewalle M., Planta Med., 20, 278-282 (1971).
19. Shibata S., Saitoh T., J. Indian Chem. Soc., 55, 1184-1191 (1978).
20. Sun J. Y., Hano Y., Nomura T., Heterocycles, 29, 195-203 (1989).
21. a) Rieseberg L. H., Soltis D. E., Doung A., Am. J. Bot., 74, 224-233 (1987);
22. b) Chemesova I. I., Bukreeva T. V., Boiko E. V. Khim. Prir. Soedin., 1990, 115-117.
23. Baba M., Ohmura (Née Matsuda) M., Kishi N., Okada Y., Shibata S., Peng J., Yao S. S., Nishino H., Okuyama T., Biol. Pharm. Bull., 23, 660-662 (2000).
24. Fukutake M., Nakatsugi S., Isoi T., Takahashi M., Ohta T., Mamiya S., Taniguchi Y., Sato H., Fukuda K., Sugimura T., Wakabayashi K., Carcinogenesis, 19, 1939-1942 (1998).
25. Smalley W. E., DuBois R. N., Adv. Pharmacol., 39, 1-20 (1997).
26. Nakadate T., Aizu E., Yamamoto S., Kato R., Prostaglandins, 30, 357-368 (1985).
27. Shureiqi I., Chen D., Lee J. J., Yang P., Newman R. A., Brenner D. E., Lotan R., Fischer S. M., Lippman S. M., J. Natl. Cancer Inst., 92, 1136-1142 (2000).